Quantum BioPharma 관리
관리 기준 확인 4/4
Quantum BioPharma's CEO is Zeeshan Saeed, appointed in Jul 2021, has a tenure of 3.33 years. total yearly compensation is $599.87K, comprised of 37.1% salary and 62.9% bonuses, including company stock and options. directly owns 6.29% of the company’s shares, worth €505.28K. The average tenure of the management team and the board of directors is 3.2 years and 3.2 years respectively.
주요 정보
Zeeshan Saeed
최고 경영자
US$599.9k
총 보상
| CEO 급여 비율 | 37.1% |
| CEO 임기 | 3.3yrs |
| CEO 소유권 | 6.3% |
| 경영진 평균 재임 기간 | 3.2yrs |
| 이사회 평균 재임 기간 | 3.2yrs |
최근 관리 업데이트
Recent updates
CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$7m |
| Mar 31 2024 | n/a | n/a | -US$10m |
| Dec 31 2023 | US$600k | US$223k | -US$18m |
| Sep 30 2023 | n/a | n/a | -US$23m |
| Jun 30 2023 | n/a | n/a | -US$29m |
| Mar 31 2023 | n/a | n/a | -US$31m |
| Dec 31 2022 | US$774k | US$239k | -US$27m |
| Sep 30 2022 | n/a | n/a | -US$27m |
| Jun 30 2022 | n/a | n/a | -US$25m |
| Mar 31 2022 | n/a | n/a | -US$30m |
| Dec 31 2021 | US$1m | US$225k | -US$34m |
| Sep 30 2021 | n/a | n/a | -US$32m |
| Jun 30 2021 | n/a | n/a | -US$39m |
| Mar 31 2021 | n/a | n/a | -US$30m |
| Dec 31 2020 | US$899k | US$212k | -US$28m |
| Sep 30 2020 | n/a | n/a | -US$36m |
| Jun 30 2020 | n/a | n/a | -US$35m |
| Mar 31 2020 | n/a | n/a | -US$41m |
| Dec 31 2019 | US$2m | US$249k | -US$34m |
| Sep 30 2019 | n/a | n/a | -US$38m |
| Jun 30 2019 | n/a | n/a | -US$25m |
| Mar 31 2019 | n/a | n/a | -US$16m |
| Dec 31 2018 | US$503k | US$183k | -US$17m |
보상 대 시장: Zeeshan's total compensation ($USD599.87K) is about average for companies of similar size in the German market ($USD488.36K).
보상과 수익: Zeeshan's compensation has been consistent with company performance over the past year.
CEO
Zeeshan Saeed (54 yo)
3.3yrs
테뉴어
US$599,873
보상
Mr. Zeeshan Saeed serves as Executive Co-Chairman at FSD Pharma Inc. since May 24, 2018 and serves as its President since July 27, 2021 and Chief Executive Officer since June 29, 2023. He serves as Co-Chai...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Founder | 3.3yrs | US$599.87k | 6.29% € 505.3k | |
| Founder & Executive Co-Chairman | 6.4yrs | US$599.87k | 5.36% € 431.1k | |
| CFO & COO | 3.3yrs | US$602.87k | 4.44% € 356.6k | |
| Controller | less than a year | US$178.21k | 0.13% € 10.8k | |
| CEO of Lucid & Director | 3.2yrs | US$521.97k | 1.17% € 94.3k | |
| Head of Finance & Mergers and Acquisitions | less than a year | 데이터 없음 | 데이터 없음 | |
| Corporate Secretary | no data | 데이터 없음 | 데이터 없음 | |
| President of FSD BioSciences | 3.7yrs | 데이터 없음 | 데이터 없음 | |
| Vice President of Clinical & Scientific Affairs of Lucid | no data | US$110.30k | 0% € 0 | |
| Vice President of Quality-Lucid | no data | US$144.82k | 데이터 없음 |
3.2yrs
평균 재임 기간
48yo
평균 연령
경험이 풍부한 관리: 0K91's management team is considered experienced (3.2 years average tenure).
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Founder | 3.5yrs | US$599.87k | 6.29% € 505.3k | |
| Founder & Executive Co-Chairman | 6.4yrs | US$599.87k | 5.36% € 431.1k | |
| CEO of Lucid & Director | 2yrs | US$521.97k | 1.17% € 94.3k | |
| Member of Research & Clinical Advisory Board | 2.8yrs | 데이터 없음 | 데이터 없음 | |
| Member of Research & Clinical Advisory Board | 3yrs | 데이터 없음 | 데이터 없음 | |
| Member of Research & Clinical Advisory Board | 3.2yrs | 데이터 없음 | 데이터 없음 | |
| Independent Director | 1.5yrs | 데이터 없음 | 데이터 없음 | |
| Independent Director | 3.4yrs | US$139.37k | 0.0077% € 620.5 | |
| Member of Research & Clinical Advisory Board | 3.2yrs | 데이터 없음 | 데이터 없음 | |
| Member of Research & Clinical Advisory Board | 3.2yrs | 데이터 없음 | 데이터 없음 | |
| Member of Research & Clinical Advisory Board | 3.2yrs | 데이터 없음 | 데이터 없음 | |
| Member of Regulatory Advisory Board | 3yrs | 데이터 없음 | 데이터 없음 |
3.2yrs
평균 재임 기간
54yo
평균 연령
경험이 풍부한 이사회: 0K91's board of directors are considered experienced (3.2 years average tenure).